Focus Partners Advisor Solutions LLC Invests $1.05 Million in Cardinal Health, Inc. $CAH

Key Points

• Focus Partners Advisor Solutions initiated a $1.05 million position in Cardinal Health, purchasing 4,438 shares during the second quarter. Institutional investors and hedge funds collectively own 87.17% of the company.
• Cardinal Health reported quarterly EPS of $2.91, beating analyst expectations of $2.42, while revenue rose 5.8% year over year to $63.67 billion but fell short of estimates. The company issued fiscal 2027 EPS guidance of $12.40–$12.60.
• Analyst sentiment remains positive, with 15 Buy ratings and three Holds, producing a “Moderate Buy” consensus and an average price target of $265.93. Cardinal also declared a quarterly dividend of $0.5158 per share, implying a 0.9% annual yield.

Focus Partners Advisor Solutions LLC bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 4,438 shares of the company's stock, valued at approximately $1,054,000.

Several other large investors have also recently bought and sold shares of CAH. University of Texas Texas AM Investment Management Co. bought a new stake in shares of Cardinal Health in the 4th quarter worth approximately $26,000. Bank of Jackson Hole Trust bought a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $27,000. Jones Financial Companies Lllp increased its position in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock valued at $27,000 after purchasing an additional 14,034 shares during the period. Palladiem LLC acquired a new position in shares of Cardinal Health in the fourth quarter valued at $28,000. Finally, Indiana Trust & Investment Management Co acquired a new position in shares of Cardinal Health in the first quarter valued at $29,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Trading Down 0.1%

NYSE CAH opened at $234.92 on Monday. The company has a market capitalization of $54.64 billion, a PE ratio of 32.49, a P/E/G ratio of 1.26 and a beta of 0.49. The stock has a 50-day simple moving average of $230.30 and a 200 day simple moving average of $217.19. Cardinal Health, Inc. has a 12 month low of $145.87 and a 12 month high of $258.30.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.42 by $0.49. The business had revenue of $63.67 billion during the quarter, compared to analysts' expectations of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.Cardinal Health's revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the prior year, the business earned $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 12.55 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be issued a $0.5158 dividend. The ex-dividend date is Thursday, October 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. Cardinal Health's dividend payout ratio (DPR) is presently 28.49%.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on CAH shares. Weiss Ratings upgraded shares of Cardinal Health from a "buy (b)" rating to a "buy (b+)" rating in a research note on Wednesday, August 5th. Bank of America upped their price objective on Cardinal Health from $240.00 to $260.00 and gave the company a "buy" rating in a research note on Thursday, July 2nd. Robert W. Baird increased their target price on Cardinal Health from $251.00 to $274.00 and gave the stock an "outperform" rating in a report on Wednesday, August 12th. William Blair initiated coverage on Cardinal Health in a research report on Tuesday, April 28th. They set an "outperform" rating for the company. Finally, Mizuho upped their price target on Cardinal Health from $240.00 to $250.00 and gave the company an "outperform" rating in a research report on Wednesday. Fifteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $265.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source